1. Home
  2. TOVX vs LFLY Comparison

TOVX vs LFLY Comparison

Compare TOVX & LFLY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TOVX
  • LFLY
  • Stock Information
  • Founded
  • TOVX 2001
  • LFLY 2010
  • Country
  • TOVX United States
  • LFLY United States
  • Employees
  • TOVX N/A
  • LFLY N/A
  • Industry
  • TOVX Biotechnology: Pharmaceutical Preparations
  • LFLY Computer Software: Prepackaged Software
  • Sector
  • TOVX Health Care
  • LFLY Technology
  • Exchange
  • TOVX Nasdaq
  • LFLY Nasdaq
  • Market Cap
  • TOVX 3.5M
  • LFLY 3.9M
  • IPO Year
  • TOVX 2006
  • LFLY N/A
  • Fundamental
  • Price
  • TOVX $1.21
  • LFLY $1.21
  • Analyst Decision
  • TOVX Strong Buy
  • LFLY Strong Buy
  • Analyst Count
  • TOVX 1
  • LFLY 2
  • Target Price
  • TOVX $6.00
  • LFLY $7.59
  • AVG Volume (30 Days)
  • TOVX 102.1K
  • LFLY 32.7K
  • Earning Date
  • TOVX 11-12-2024
  • LFLY 11-07-2024
  • Dividend Yield
  • TOVX N/A
  • LFLY N/A
  • EPS Growth
  • TOVX N/A
  • LFLY N/A
  • EPS
  • TOVX N/A
  • LFLY N/A
  • Revenue
  • TOVX N/A
  • LFLY $35,868,000.00
  • Revenue This Year
  • TOVX N/A
  • LFLY N/A
  • Revenue Next Year
  • TOVX N/A
  • LFLY N/A
  • P/E Ratio
  • TOVX N/A
  • LFLY N/A
  • Revenue Growth
  • TOVX N/A
  • LFLY N/A
  • 52 Week Low
  • TOVX $1.14
  • LFLY $1.20
  • 52 Week High
  • TOVX $17.00
  • LFLY $5.88
  • Technical
  • Relative Strength Index (RSI)
  • TOVX 37.37
  • LFLY 34.88
  • Support Level
  • TOVX $1.15
  • LFLY $1.20
  • Resistance Level
  • TOVX $1.34
  • LFLY $1.35
  • Average True Range (ATR)
  • TOVX 0.07
  • LFLY 0.08
  • MACD
  • TOVX 0.01
  • LFLY 0.00
  • Stochastic Oscillator
  • TOVX 7.41
  • LFLY 16.92

About TOVX Theriva Biologics Inc.

Theriva Biologics Inc is a clinical-stage pharmaceutical company developing a novel oncolytic adenovirus (OV) platform to address devastating cancers with high unmet needs. It is a lead clinical-stage program VCN-01, designed to break down the tumor stroma, and its preclinical-stage program VCN-11 leverages its proprietary Albumin Shield Technology to protect systemically administered oncolytic viruses from the host immune system.

About LFLY Leafly Holdings Inc.

Leafly Holdings Inc operates an online cannabis information resource platform. It offers cannabis retailers and brands subscription-based marketplace listings that provide its cannabis audience with information, reviews, menus, and ordering and delivery options through legal retailers.

Share on Social Networks: